Holen Sie sich die Stockscreener-App
8.05
0.98%
-0.08
Vorhandelsmarkt:
8.04
-0.01
-0.12%
Pavmed Inc Aktie (PAVM) Neueste Nachrichten
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Q3 2025 PAVmed Inc Earnings Call Transcript - GuruFocus
Q1 2025 PAVmed Inc Earnings Call Transcript - GuruFocus
PAVmed Inc (FRA:1P5) Stock Earnings Transcripts - GuruFocus
PAVmed Inc (FRA:1P5) Stock Price & 30 Year Financial Data - GuruFocus
PAVmed Inc (FRA:1P5) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
PAVmed (PAVM) 2026 proxy: ESPP share increase, director elections and auditor vote - Stock Titan
PAVmed will outline Q1 results and strategy in a May 15 webcast - Stock Titan
[ARS] PAVmed Inc. SEC Filing - Stock Titan
Lucid Diagnostics (NASDAQ: LUCD) seeks big share increase in 2026 proxy - Stock Titan
Lucid Diagnostics to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 14, 2026 - BioSpace
Lucid Diagnostics to Hold First Quarter 2026 Business Update Con - GuruFocus
Lucid Diagnostics will detail Q1 results and strategy on May 14 - Stock Titan
[EFFECT] PAVmed Inc. SEC Filing - Stock Titan
SEC Form DEFA14A filed by PAVmed Inc. - Quantisnow
PAVmed Inc. (NASDAQ: PAVM) registers 9.23M shares from Series D conversion - Stock Titan
PAVM Technical Analysis | Trend, Signals & Chart Patterns | PAVMED INC (NASDAQ:PAVM) - ChartMill
PAVmed (PAVM) price target decreased by 84.60% to 41.31 - MSN
PAVmed Inc (STU:1P5) Stock PDF (Updated: 2026/04/28) - GuruFocus
Debt to equity ratio of PAVmed, Inc. – FWB:1P5 - TradingView
Pretax income of PAVmed, Inc. – FWB:1P5 - TradingView
Free cash flow of PAVmed, Inc. – FWB:1P5 - TradingView
Return on invested capital % of PAVmed, Inc. – FWB:1P5 - TradingView
Taxes of PAVmed, Inc. – FWB:1P5 - TradingView
Debt to assets ratio of PAVmed, Inc. – FWB:1P5 - TradingView
Total equity of PAVmed, Inc. – FWB:1P5 - TradingView
PAVmed (PAVM) upgraded to buy: Here's what you should know - MSN
PAVmed Q2 2025 Earnings Preview - MSN
Why The PAVmed (PAVM) Story Is Shifting After A Major Valuation Reset - Yahoo Finance
Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock - marketscreener.com
PAVmed (PAVM) price target increased by 2,900.00% to 321.30 - MSN
Lucid Diagnostics Raises Capital Through Direct Share Offering - The Globe and Mail
Lucid Diagnostics closes $18M stock offering at $1 per share - Investing.com Australia
Latest PAVM NewsPAVmed Collaborates with Canon on DisappEAR... - Stock Titan
Lucid Diagnostics (NASDAQ: LUCD) closes $18M underwritten stock sale - Stock Titan
Lucid Diagnostics closes $18M stock offering at $1 per share By Investing.com - Investing.com India
Lucid Diagnostics prices $18M stock offering at $1 per share - Investing.com India
Backed by a $15M investor, Lucid closes $18M share sale - Stock Titan
Lucid Diagnostics Prices $18 Million Public Equity Offering - TipRanks
Lucid Diagnostics (Nasdaq: LUCD) prices $18M underwritten stock sale - Stock Titan
Lucid Diagnostics prices $18M stock offering at $1 per share By Investing.com - Investing.com South Africa
Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock - Financial Times
A $15M anchor investor backs Lucid’s 18M-share stock sale - Stock Titan
PAVmed Inc. (PAVM) posts narrow Q4 2025 EPS miss, shares edge higher in muted investor trading.Community Exit Signals - Cổng thông tin điện tử tỉnh Tây Ninh
PAVmed (NASDAQ: PAVM) registers 9.23M common shares; $30M potential from warrants - Stock Titan
PAVmed IncFiles Prospectus For Potential Offer And Sale Of 9.23 Million Common Shares By Selling StockholdersSEC Filing - TradingView
Lucid Diagnostics (NASDAQ: LUCD) seeks 100M-share authorization increase - Stock Titan
PAVmed Inc. Series Z Warrant (PAVMZ) - Minichart
PAVmed (PAVM) Stock Resistance Rejection (+0.11%) 2026-04-18Sentiment Analysis - Xã Vĩnh Công
0.41%
0.93%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):